Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
110 hedge funds and large institutions have $120M invested in Immunomedics Inc in 2016 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 23 increasing their positions, 35 reducing their positions, and 12 closing their positions.
192% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 12
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
74% more call options, than puts
Call options by funds: $6.17M | Put options by funds: $3.54M
26% more funds holding
Funds holding: 87 → 110 (+23)
34% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 35
60% less capital invested
Capital invested by funds: $301M → $120M (-$181M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$25.1M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
+$8.02M |
| 3 |
Renaissance Technologies
New York
|
+$5.92M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$3.34M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$33.5M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$4.43M |
| 3 |
PA
Perceptive Advisors
New York
|
-$4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.3M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.86M |
IMMU Hedge Fund Activity: Q2 2016 in Review
110 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2016, worth a combined $120M — down 60% from $301M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new IMMU positions and 12 closed out — a net gain of 23 holders — while 23 added to existing stakes and 35 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $25.1M. The largest seller was Fidelity Investments, cutting an estimated $33.5M.
- 110 institutional investors held Immunomedics Inc (IMMU) as of Q2 2016, up from 87 in Q1 2016.
- Funds reported $120M of Immunomedics Inc stock for Q2 2016, down 60% quarter-over-quarter.
- 35 funds opened new Immunomedics Inc positions in Q2 2016 and 12 closed out, a net change of +23 holders.
- The largest Immunomedics Inc buyer in Q2 2016 was Avoro Capital Advisors, an estimated $25.1M added.
- The largest Immunomedics Inc seller in Q2 2016 was Fidelity Investments, an estimated $33.5M sold.
Based on aggregated 13F filings for Q2 2016.